Bruna Manoel

My career is a story of curiosity, growth, and impactful innovation. Starting as a medical doctor, I quickly realized my passion extended beyond patient care into the broader world of drug development and business strategy. Over the years, I've cultivated expertise in biomarker-driven drug development, nurtured strategic business alliances, and achieved significant commercial success, notably driving a 90% organic sales increase.

With over five years of dedicated project management experience, I've guided complex projects from inception to successful execution, consistently translating intricate scientific concepts into tangible, life-improving outcomes.

Today, I thrive in environments where clinical insights meet entrepreneurial action, always eager to foster innovation and strategic collaborations that make a real difference.

Key Qualifications and Experience:

• Experienced Medical Doctor with extensive knowledge of clinical medicine and drug development.
• MBA in Bioentrepreneurship from CBS, skilled in strategic commercialization and innovative business development within the life sciences industry.
• Demonstrated ability in driving growth through strategic business initiatives, resulting in substantial success (90% organic sales growth).
• Proven expertise in clinical project management (PRINCE2 certified), adept at leading cross-functional teams to achieve operational excellence.

• PRINCE2 Foundation Certification, Alexos, 2021
• Good Clinical Practice (GCP) Certification, Nida, 2021
• Good Clinical Laboratory Practice, Sep 2022
• Medical License, Cremesp, Jan 2013

• HØJBERG Prize 2021

• "Diagnostic potential of blood-based biomarkers in multiple sclerosis" - Frontiers in Neurology, Dec 31, 2024
• "Biomarker-guided drug development provides value for patients, payers and drug developers: lessons learned from 25 years in the biomarker industry.Biomarker-guided drug development provides value for patients, payers and drug developers: lessons learned from 25 years in the biomarker industry. " Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2024-04 · May 28, 2024
• "The caspase-generated tau-fragment, tau-c, is a sensitive serum marker for detection of parkinson’s diseaseThe caspase-generated tau-fragment, tau-c, is a sensitive serum marker for detection of parkinson’s disease." International Conference on Alzheilmer´s and Parkinson´s Diseases and related neurological disorders (AD/PD) · Mar 6, 2024

• Outside of my professional interests, I enjoy sailing, which helps me stay focused and
  embrace challenges in both calm and turbulent situations. Yoga is also an important part of
  my routine, allowing me to maintain balance and mindfulness. Additionally, I mentor science
  students at Synapse – Life Science Connect, where I actively support the next generation of
  innovators in the life sciences field.